Navigation Links
WallSt.net Updates Investment Community Through All-New Interview With Transplant Creations
Date:1/16/2008

NEW YORK, Jan. 16 /PRNewswire/ -- On January 10, Dr. Marlies Van Hoef, CEO of Transplant Creations (http://www.transplantcreations.com) updated the investment community in an all-new interview with http://www.wallst.net. Topics covered in the interview include an overview of the company, recent press, the market opportunity and upcoming milestones for which investors should watch.

To hear the interview in its entirety, visit the Company website at http://www.transplantcreations.com or go to http://www.wallst.net/audio/audio.asp?ticker=PRIVATE&id=4341.

About Transplant Creations:

Experienced in evaluation of the therapeutic potential of products, Transplant Creations' service department provides advice in strategic planning during the preclinical stage of development, during early or late stage clinical development, or at a moment that companies consider acquisition or development of a product in a therapeutic area within our focus.

Specialized in hematopoietic stem cell transplantation with a focus on malignant diseases and a back-ground in oncology and hematology the Company has developed a unique "delivery method" for "drug combinations", autologous stem cell support and allogeneic hematopoietic stem cell grafting.

The investment sector has been focusing on drugs and technologies as targets for investment, said Van Hoef, we focus on method development through same clinical research principles as drug development.

Van Hoef emphasized that there is an opportunity for investment in methods that has remained unexplored. The Company's unique method offers superior perspectives for disease outcome.

The mission for 2008 and beyond is to invite investors and the public to get involved in implementation of the method.

For more information, please visit http://www.transplantcreations.com.

About WallSt.net:

http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The Web site is a leading provider of timely business news, executive interviews, multimedia content and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net, a financial social network for investors, and Financial Filings Corp., a provider of compliance solutions to publicly traded companies. Additionally, WallStreet Direct, Inc. owns and operates WallStRadio, a business and finance podcast Web site. Financial Filings Corp. is expecting to receive two hundred eighty dollars from Transplant Creations for the dissemination of this press release. For a complete list of our advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

Contact: WallSt.net

800-4-WALLST


'/>"/>
SOURCE WallStreet Direct, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WallSt.net Announces Upcoming Interview With CEO of Avicena Group
2. WallSt.net Announces Upcoming Interview with CSO and COO of Urigen Pharmaceuticals
3. WallSt.net Announces Upcoming Interview With CEO of Alliance HealthCard
4. Skystar Bio-Pharmaceutical Announces Upcoming Interview With WallSt.net ( www.wallst.net )
5. WallSt.net (www.wallst.net) Updates the Investment Community Through All-New Interviews With XMDC, POSS and TYPE
6. WallSt.net Updates Investment Community Through All-New Interview With XTend Medical
7. WallSt.net Updates Investment Community Through All-New Interview With Ingen Technologies
8. PPD Updates 2007 Forecast; Issues Financial Guidance for 2008
9. Cardiome Updates Guidance
10. Silverchair Learning Systems Updates and Develops New Courses
11. eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... ... Valentine’s Day is nearly upon us, and most singles could probably use ... hair, and a sparkling personality are all well and good, but if somebody smells ... with Rover. (Actually, man’s best friend might not even want to be near those ...
(Date:2/13/2016)... FL (PRWEB) , ... February 13, 2016 , ... The ... environmental impact of American businesses. , The increasingly modern world of instantaneous consumption ... often on non-renewable energy sources such as oil and coal, which pollutes our air, ...
(Date:2/13/2016)... ... ... In the early or “honeymoon” stage of a relationship, couples strive to put ... to be romantic, and may exaggerate a strength or two in an effort to ... , A recent study from Queendom.com , however, suggests that new couples who ...
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of ... Evangeline Parishes. The purpose of these scholarships is to encourage applicants to pursue ... to seek employment within these two parishes. , “We have available jobs in ...
(Date:2/12/2016)... Falls Church, VA (PRWEB) , ... February 12, ... ... in Store?, Feb. 29, 2016 — 1:30 p.m. – 3:00 p.m. EST, ... burner issue in the life cycle of pharmaceutical products, garnering increased attention from ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... 11, 2016 Stem cells are primitive cells ... self-renewal and the capacity to differentiate into mature cell ... as the first mouse embryonic stem cells were derived ... 1995 that the first culturing of embryonic stem cells ... not produced until 2006 As a result of these ...
(Date:2/11/2016)... , Feb. 11, 2016  Kindred Biosciences, Inc. ... saving and improving the lives of pets, today announced ... of the New Animal Drug Application (NADA) for Zimeta™ ... field study (KB0120) of Zimeta for the control of ... Company. --> --> ...
(Date:2/11/2016)... 2016   Health 2.0 , the premiere showcase ... announced today " 10 Year Global Retrospective ", a ... the past ten years.   --> ... 2.0 has served as the preeminent thought-leader in the ... of technologies, companies, innovators, and patient-activists through an array ...
Breaking Medicine Technology: